CHILDHOOD BONE SIZE, MINERALIZATION AND DENSITY ARE ASSOCIATED WITH METHYLATION STATUS OF THE CDKN2A PROMOTER AT BIRTH

被引：0
|
作者：
Harvey, Nicholas C. [1 ]
Clarke-Harris, Rebecca [2 ]
Murray, Rob [2 ]
Costello, Paula [2 ]
Garrett, Emma [2 ]
Holbrook, Joanna [3 ]
Teh, Ai-Ling [3 ]
Wong, Johnny [3 ]
Dogra, Shaillay [3 ]
Barton, Sheila [1 ]
Davies, Lucy [1 ]
Inskip, Hazel [1 ]
Hanson, Mark [2 ]
Gluckman, Peter [3 ,4 ]
Cooper, Cyrus [1 ]
Godfrey, Keith [1 ,5 ,6 ]
Lillycrop, Karen [2 ]
机构：
[1] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England
[2] Univ Southampton, Inst Dev Sci, Southampton, Hants, England
[3] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore
[4] Univ Auckland, Liggins Inst, Auckland 1, New Zealand
[5] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England
[6] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England
来源：
RHEUMATOLOGY | 2013年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [41] Association of Peripheral Blood RASSF1A and CDKN2A Methylation Status with Smoking Behaviour in Nasopharyngeal Carcinoma
    Risanti, Erika Diana
    Kurniawan, Aditya
    Wahyuningsih, Laila
    Dwianingsih, Ery Kus
    Rinonce, Hanggoro Tri
    Fachiroh, Jajah
    INDONESIAN BIOMEDICAL JOURNAL, 2018, 10 (02): : 123 - 127
  • [42] p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus
    Bian, YS
    Osterheld, MC
    Fontolliet, C
    Bosman, FT
    Benhattar, J
    GASTROENTEROLOGY, 2002, 122 (04) : 1113 - 1121
  • [43] Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas
    Ye, Chuanzhong
    Shrubsole, Martha J.
    Cai, Qiuyin
    Ness, Reid
    Grady, William M.
    Smalley, Walter
    Cai, Hui
    Washington, Kay
    Zheng, Wei
    ONCOLOGY REPORTS, 2006, 16 (02) : 429 - 435
  • [44] Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer
    Riese, U
    Dahse, R
    Fiedler, W
    Theuer, C
    Koscielny, S
    Ernst, G
    Beleites, E
    Claussen, U
    von Eggeling, F
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1999, 4 (01) : 61 - 65
  • [45] Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity
    Yakushiji, T
    Uzawa, K
    Shibahara, T
    Noma, H
    Tanzawa, H
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 22 (06) : 1201 - 1207
  • [46] Clinical and prognostic effects of CDKN2A, CDKN2B and CDH13 promoter methylation in ovarian cancer: a study using meta-analysis and TCGA data
    Xia, Liang
    Zhang, Wenzhu
    Gao, Li
    BIOMARKERS, 2019, 24 (07) : 700 - 711
  • [47] Correlation of CDKN2A Promoter Methylation Status with Loss of p16 Expression in Atypical Spitz Nevi and Spitzoid Melanoma Using the Digital Droplet PCR (ddPCR) Method
    Rahi, Hamed
    Milosevic, Dragana
    Guo, Ruifeng
    Geiersbach, Katherine
    LABORATORY INVESTIGATION, 2023, 103 (03) : S428 - S429
  • [48] Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia
    Hatzimichael, Eleftheria
    Benetatos, Leonidas
    Dasoula, Aggeliki
    Dranitsaris, George
    Tsiara, Stavroula
    Georgiou, Ioannis
    Syrrou, Maria
    Stebbing, Justin
    Coley, Helen M.
    Crook, Tim
    Bourantas, Konstantinos L.
    LEUKEMIA RESEARCH, 2009, 33 (09) : 1272 - 1275
  • [49] Methylation status of p16/CDKN2A in oral squamous cell carcinoma and correlation with DNA methyltransferases expression.
    Yakushiji, T
    Uzawa, K
    Tanaka, C
    Yamamoto, N
    Shibahara, T
    Noma, H
    Tanzawa, H
    JOURNAL OF DENTAL RESEARCH, 2002, 81 : A201 - A201
  • [50] Nonpromoter methylation of the CDKN2A gene with active transcription is associated with improved locoregional control in laryngeal squamous cell carcinoma
    Ben-Dayan, Miriam M.
    Ow, Thomas J.
    Belbin, Thomas J.
    Wetzler, Joshua
    Smith, Richard V.
    Childs, Geoffrey
    Diergaarde, Brenda
    Hayes, D. Neil
    Grandis, Jennifer R.
    Prystowsky, Michael B.
    Schlecht, Nicolas F.
    CANCER MEDICINE, 2017, 6 (02): : 397 - 407
12345